Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Assets: 2019-2025

Historic Current Assets for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $33.4 million.

  • Biodesix's Current Assets fell 24.12% to $33.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year decrease of 24.12%. This contributed to the annual value of $39.5 million for FY2024, which is 0.50% down from last year.
  • According to the latest figures from Q3 2025, Biodesix's Current Assets is $33.4 million, which was up 2.95% from $32.4 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Current Assets registered a high of $81.2 million during Q1 2021, and its lowest value of $24.1 million during Q3 2022.
  • Moreover, its 3-year median value for Current Assets was $33.4 million (2025), whereas its average is $35.8 million.
  • In the last 5 years, Biodesix's Current Assets spiked by 211.01% in 2021 and then tumbled by 66.48% in 2022.
  • Over the past 5 years, Biodesix's Current Assets (Quarterly) stood at $43.6 million in 2021, then grew by 22.29% to $53.3 million in 2022, then decreased by 25.60% to $39.7 million in 2023, then dropped by 0.50% to $39.5 million in 2024, then decreased by 24.12% to $33.4 million in 2025.
  • Its last three reported values are $33.4 million in Q3 2025, $32.4 million for Q2 2025, and $29.6 million during Q1 2025.